CJC 1295 with DAC
$47.00
CJC-1295 with DAC, also known as CJC-1295 with Drug Affinity Complex, is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to enhance plasma growth hormone levels over a longer duration compared to CJC-1295 without DAC (Lahlou et al., 1999). DAC is a component that lengthens the half-life of CJC-1295, making the stimulation of growth hormone more steady and sustained (Teichman et al., 2006).
What is CJC-1295 with DAC?
CJC-1295 with DAC, also known as CJC-1295 with Drug Affinity Complex, is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to enhance plasma growth hormone levels over a longer duration compared to CJC-1295 without DAC (Lahlou et al., 1999). DAC is a component that lengthens the half-life of CJC-1295, making the stimulation of growth hormone more steady and sustained (Teichman et al., 2006).
What is the key mechanism of action for CJC-1295 with DAC?
CJC-1295 with DAC works by binding to the growth hormone secretagogue receptor (GHSR) in the pituitary gland. It stimulates the release of growth hormone in pulses, but the presence of DAC extends the duration of GH release, resulting in an overall higher level of circulating growth hormone (Ionescu et al., 2005; Teichman et al., 2006).
What are some of the benefits of CJC-1295 with DAC?
CJC-1295 with DAC and Muscle Growth: Research suggests that the extended release of growth hormone associated with CJC-1295 with DAC may enhance muscle growth and development (Teichman et al., 2006).
CJC-1295 with DAC and Fat Loss: Studies suggest that CJC-1295 with DAC may have potential benefits on fat metabolism, leading to reductions in body fat (Lahlou et al., 1999).
CJC-1295 with DAC and Aging: As growth hormone levels tend to decline with age, CJC-1295 with DAC has been studied for its potential anti-aging benefits, through the restoration of growth hormone levels (Ionescu et al., 2005).
CJC-1295 with DAC and Wound Healing: The increased GH release could potentially enhance the rate of wound healing due to the role of growth hormone in tissue regeneration (Lahlou et al., 1999).
References:
Lahlou, N., Roger, M., & Limoni, C. (1999). The effect of a long-acting formulation of the growth hormone-releasing peptide-2 (GHRP-2) on various hormones, serum constituents, body weight and body composition in healthy volunteers. Clinical Endocrinology, 51(6), 749-756.
Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
Ionescu, M., Frohman, L. A. (2005). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology & Metabolism, 90(12), 6296-6303.
